Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study

BACKGROUND: Angiogenesis is essential for the progression and metastatic spread of solid tumours. Expression of vascular endothelial growth factor (VEGF) has been linked to poor survival among osteosarcoma patients but the clinical relevance of monitoring blood and urine angiogenic factors is uncert...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Tabone, Marie-Dominique, Brugières, Laurence, Piperno-Neumann, Sophie, Selva, Marie-Ange, Marec-Bérard, Perrine, Pacquement, Hélène, Lervat, Cyril, Corradini, Nadège, Gentet, Jean-Claude, Couderc, Rémy, Chevance, Aurélie, Mahier-Ait Oukhatar, Céline, Entz-Werle, Natacha, Blay, Jean-Yves, Le Deley, Marie-Cecile
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5473001/
https://ncbi.nlm.nih.gov/pubmed/28619014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3409-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares